Symbols / IMCR Stock $29.23 -2.50% Immunocore Holdings plc

Healthcare • Biotechnology • United Kingdom • NMS
IMCR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Stock Fundamentals
Scroll to Statements
Market Cap 1.49B Enterprise Value 1.05B Income -35.51M Sales 400.02M Book/sh 7.52 Cash/sh 17.05
Dividend Yield — Payout 0.00% Employees 524 IPO — P/E — Forward P/E -20.86
PEG — P/S 3.71 P/B 3.89 P/C — EV/EBITDA -47.16 EV/Sales 2.64
Quick Ratio 3.91 Current Ratio 4.04 Debt/Eq 114.61 LT Debt/Eq — EPS (ttm) -0.71 EPS next Y -1.40
EPS Growth — Revenue Growth 24.30% Earnings 2026-05-06 ROA -1.54% ROE -9.58% ROIC —
Gross Margin 96.53% Oper. Margin 0.03% Profit Margin -8.88% Shs Outstand 50.83M Shs Float 45.06M Short Float 27.51%
Short Ratio 26.65 Short Interest — 52W High 40.72 52W Low 27.44 Beta 0.83 Avg Volume 425.85K
Volume 317.13K Target Price $63.86 Recom Buy Prev Close $29.98 Price $29.23 Change -2.50%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$63.86
Mean price target
2. Current target
$29.23
Latest analyst target
3. DCF / Fair value
$8.48
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$29.23
Low
$33.00
High
$100.00
Mean
$63.86

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 reit HC Wainwright & Co. Buy → Buy $100
2026-04-14 reit HC Wainwright & Co. Buy → Buy $100
2026-03-16 down Jefferies Buy → Hold $33
2026-02-26 main Needham Buy → Buy $75
2026-02-04 reit HC Wainwright & Co. Buy → Buy $100
2025-11-10 main Morgan Stanley Equal-Weight → Equal-Weight $36
2025-10-31 init Wells Fargo — → Overweight $60
2025-10-22 reit HC Wainwright & Co. Buy → Buy $100
2025-06-02 reit HC Wainwright & Co. Buy → Buy $100
2025-05-08 main Oppenheimer Outperform → Outperform $86
2025-04-14 main JP Morgan Overweight → Overweight $50
2025-04-10 reit Needham Buy → Buy $71
2025-04-07 main Mizuho Neutral → Neutral $33
2025-03-12 reit HC Wainwright & Co. Buy → Buy $100
2025-03-12 reit Needham Buy → Buy $71
2025-03-05 reit HC Wainwright & Co. Buy → Buy $100
2025-02-28 reit HC Wainwright & Co. Buy → Buy $100
2025-02-27 reit Needham Buy → Buy $71
2025-01-27 reit HC Wainwright & Co. Buy → Buy $100
2025-01-10 reit Needham Buy → Buy $71
News
RSS: Latest IMCR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-18 JALLAL BAHIJA Chief Executive Officer — 11,474 $32.35 $371,184
2026-02-18 GOLL JOHN R Officer — 698 $32.35 $22,580
2026-02-18 BERMAN DAVID M Officer — 5,965 $32.35 $192,968
2026-02-18 ST LEGER TINA AMBER Officer — 1,000 $32.35 $32,350
2026-02-17 JALLAL BAHIJA Chief Executive Officer — 23,817 — —
2026-02-17 GOLL JOHN R Officer — 1,351 — —
2026-02-17 BERMAN DAVID M Officer — 11,824 — —
2026-02-17 ST LEGER TINA AMBER Officer — 2,119 — —
2025-12-04 BERMAN DAVID M Officer — 31,341 $40.22 $1,260,378
2025-11-28 BERMAN DAVID M Officer — 74,925 $40.09 $3,005,825
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
400.02
+28.95%
310.20
+24.37%
249.43
+43.05%
174.36
Operating Revenue
400.02
+28.95%
310.20
+24.37%
249.43
+43.05%
174.36
Cost Of Revenue
5.09
+86.27%
2.73
+163.36%
1.04
-4.78%
1.09
Reconciled Cost Of Revenue
5.09
+86.27%
2.73
+163.36%
1.04
-4.78%
1.09
Gross Profit
394.93
+28.44%
307.47
+23.79%
248.39
+43.35%
173.27
Operating Expense
440.28
+16.50%
377.93
+22.69%
308.04
+36.92%
224.98
Research And Development
274.87
+23.73%
222.15
+35.83%
163.54
+60.46%
101.92
Selling General And Administration
165.41
+6.18%
155.78
+7.81%
144.50
+17.42%
123.06
General And Administrative Expense
—
—
—
—
Other Gand A
—
—
—
—
Other Operating Expenses
—
—
—
—
Total Expenses
445.37
+17.00%
380.66
+23.16%
309.08
+36.72%
226.07
Operating Income
-45.35
+35.63%
-70.46
-18.13%
-59.65
-15.36%
-51.71
Total Operating Income As Reported
-45.35
+35.63%
-70.46
-18.13%
-59.65
-15.36%
-51.71
EBITDA
-3.67
+87.73%
-29.89
+42.13%
-51.65
-71.36%
-30.14
Normalized EBITDA
-5.88
+77.75%
-26.44
+31.27%
-38.47
+13.15%
-44.30
Reconciled Depreciation
3.27
-22.31%
4.20
+2.79%
4.09
-23.34%
5.33
EBIT
-6.93
+79.66%
-34.09
+38.83%
-55.74
-57.12%
-35.47
Total Unusual Items
2.21
+164.24%
-3.45
+73.83%
-13.18
-193.07%
14.16
Total Unusual Items Excluding Goodwill
2.21
+164.24%
-3.45
+73.83%
-13.18
-193.07%
14.16
Special Income Charges
—
—
—
0.00
Net Income
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Pretax Income
-19.10
+63.92%
-52.94
+13.06%
-60.89
-48.94%
-40.88
Net Non Operating Interest Income Expense
4.31
-36.37%
6.77
-47.21%
12.83
+876.29%
-1.65
Interest Expense Non Operating
12.17
-35.44%
18.84
+265.62%
5.15
-4.71%
5.41
Net Interest Income
4.31
-36.37%
6.77
-47.21%
12.83
+876.29%
-1.65
Interest Expense
12.17
-35.44%
18.84
+265.62%
5.15
-4.71%
5.41
Interest Income Non Operating
16.48
-35.69%
25.62
+42.43%
17.99
+378.86%
3.76
Interest Income
16.48
-35.69%
25.62
+42.43%
17.99
+378.86%
3.76
Other Income Expense
21.94
+104.12%
10.75
+176.39%
-14.07
-212.78%
12.48
Other Non Operating Income Expenses
19.73
+38.95%
14.20
+1682.83%
-0.90
+46.58%
-1.68
Gain On Sale Of Security
2.21
+164.24%
-3.45
+73.83%
-13.18
-193.07%
14.16
Tax Provision
16.41
+987.24%
-1.85
+66.98%
-5.60
-148.05%
11.66
Tax Rate For Calcs
0.00
+500.91%
0.00
-62.01%
0.00
-67.72%
0.00
Tax Effect Of Unusual Items
0.47
+486.02%
-0.12
+90.06%
-1.21
-130.04%
4.03
Net Income Including Noncontrolling Interests
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Net Income From Continuing Operation Net Minority Interest
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Net Income From Continuing And Discontinued Operation
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Net Income Continuous Operations
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Normalized Income
-37.26
+21.98%
-47.76
-10.24%
-43.32
+30.87%
-62.67
Net Income Common Stockholders
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Diluted EPS
-0.71
+30.39%
-1.02
+9.73%
-1.13
-3.75%
-1.09
Basic EPS
-0.71
+30.39%
-1.02
+9.73%
-1.13
-3.75%
-1.09
Basic Average Shares
50.35
+0.71%
49.99
+2.25%
48.89
+6.73%
45.80
Diluted Average Shares
50.35
+0.71%
49.99
+2.25%
48.89
+6.73%
45.80
Diluted NI Availto Com Stockholders
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Gain On Sale Of PPE
—
—
—
0.00
Total Other Finance Cost
—
—
—
1.69
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,067.27
+5.72%
1,009.51
+69.10%
597.00
+13.33%
526.76
Current Assets
996.74
+7.19%
929.86
+75.84%
528.82
+11.57%
473.98
Cash Cash Equivalents And Short Term Investments
864.15
+5.34%
820.38
+85.34%
442.63
+9.98%
402.47
Cash And Cash Equivalents
467.71
+2.63%
455.73
+2.96%
442.63
+9.98%
402.47
Cash Financial
—
—
—
332.54
Other Short Term Investments
396.44
+8.72%
364.64
0.00
—
Receivables
101.12
+21.69%
83.10
+35.26%
61.44
+7.62%
57.08
Accounts Receivable
73.98
+17.41%
63.01
+20.95%
52.09
+55.11%
33.58
Gross Accounts Receivable
—
—
52.63
+56.71%
33.58
Allowance For Doubtful Accounts Receivable
—
—
-0.54
0.00
Other Receivables
—
—
—
18.98
Taxes Receivable
27.14
+35.13%
20.09
+115.02%
9.34
-60.25%
23.50
Inventory
6.74
+23.80%
5.45
+21.00%
4.50
+550.43%
0.69
Prepaid Assets
17.98
+37.76%
13.05
+23.71%
10.55
+4.33%
10.11
Other Current Assets
6.75
-14.52%
7.90
-18.67%
9.71
+168.19%
3.62
Total Non Current Assets
70.53
-11.44%
79.64
+16.81%
68.18
+29.17%
52.78
Net PPE
50.24
+5.26%
47.73
+11.70%
42.73
+10.21%
38.78
Gross PPE
111.05
+7.76%
103.06
+8.43%
95.04
+12.55%
84.44
Accumulated Depreciation
-60.80
-9.91%
-55.32
-5.76%
-52.31
-14.54%
-45.67
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.86
+9.14%
3.53
+83.87%
1.92
+12.40%
1.71
Construction In Progress
1.13
+137.74%
0.48
+936.96%
0.05
-89.33%
0.43
Other Properties
83.64
+7.19%
78.03
+6.80%
73.05
+15.58%
63.21
Leases
22.42
+6.66%
21.02
+5.00%
20.02
+4.84%
19.09
Goodwill And Other Intangible Assets
—
—
—
0.41
Investments And Advances
—
—
—
0.14
Other Investments
—
—
—
—
Non Current Deferred Assets
0.00
-100.00%
14.79
+34.79%
10.97
+114.27%
5.12
Non Current Deferred Taxes Assets
0.00
-100.00%
14.79
+34.79%
10.97
+114.27%
5.12
Non Current Prepaid Assets
—
—
—
7.21
Other Non Current Assets
20.28
+18.49%
17.12
+18.27%
14.47
+62.86%
8.89
Total Liabilities Net Minority Interest
686.24
+5.77%
648.79
+184.36%
228.16
+21.45%
187.86
Current Liabilities
246.70
+16.27%
212.18
+52.63%
139.02
+37.87%
100.83
Payables And Accrued Expenses
227.57
+15.20%
197.53
+56.73%
126.03
+53.61%
82.05
Payables
24.36
-2.93%
25.10
+41.03%
17.80
+14.29%
15.57
Accounts Payable
24.36
-2.93%
25.10
+41.03%
17.80
+23.17%
14.45
Current Accrued Expenses
203.20
+17.84%
172.43
+59.31%
108.24
+62.82%
66.47
Pensionand Other Post Retirement Benefit Plans Current
16.54
+26.26%
13.10
+12.97%
11.60
+26.75%
9.15
Total Tax Payable
—
—
1.81
+61.05%
1.12
Current Debt And Capital Lease Obligation
2.01
+29.67%
1.55
+11.46%
1.39
-26.25%
1.88
Current Capital Lease Obligation
2.01
+29.67%
1.55
+11.46%
1.39
-26.25%
1.88
Current Deferred Liabilities
0.58
0.00
0.00
-100.00%
7.76
Current Deferred Revenue
0.58
0.00
0.00
-100.00%
7.76
Total Non Current Liabilities Net Minority Interest
439.54
+0.67%
436.61
+389.82%
89.14
+2.43%
87.02
Long Term Debt And Capital Lease Obligation
434.68
+0.81%
431.18
+415.62%
83.62
+5.10%
79.57
Long Term Debt
393.12
+0.54%
391.01
+714.42%
48.01
+0.43%
47.81
Long Term Capital Lease Obligation
41.56
+3.47%
40.16
+12.78%
35.61
+12.13%
31.76
Long Term Provisions
—
—
—
0.11
Non Current Deferred Liabilities
4.86
-10.60%
5.43
-1.47%
5.51
+5.21%
5.24
Non Current Deferred Revenue
4.86
-10.60%
5.43
-1.47%
5.51
+5.21%
5.24
Stockholders Equity
381.03
+5.63%
360.72
-2.20%
368.84
+8.83%
338.90
Common Stock Equity
381.03
+5.63%
360.72
-2.20%
368.84
+8.83%
338.90
Capital Stock
0.14
+0.74%
0.14
+0.75%
0.13
+3.88%
0.13
Common Stock
0.14
+0.74%
0.14
+0.75%
0.13
+3.88%
0.13
Share Issued
50.69
+1.25%
50.06
+0.68%
49.73
+3.40%
48.09
Ordinary Shares Number
50.69
+1.25%
50.06
+0.68%
49.73
+3.40%
48.09
Additional Paid In Capital
1,240.26
+4.21%
1,190.10
+3.52%
1,149.64
+6.17%
1,082.83
Retained Earnings
-831.27
-4.46%
-795.76
-6.86%
-744.67
-8.02%
-689.39
Gains Losses Not Affecting Retained Earnings
-28.08
+16.82%
-33.76
+6.89%
-36.26
+33.68%
-54.67
Other Equity Adjustments
-28.08
+16.82%
-33.76
+6.89%
-36.26
+33.68%
-54.67
Total Equity Gross Minority Interest
381.03
+5.63%
360.72
-2.20%
368.84
+8.83%
338.90
Total Capitalization
774.16
+2.98%
751.73
+80.33%
416.85
+7.79%
386.71
Working Capital
750.04
+4.51%
717.68
+84.12%
389.80
+4.46%
373.14
Invested Capital
774.16
+2.98%
751.73
+80.33%
416.85
+7.79%
386.71
Total Debt
436.69
+0.92%
432.72
+409.02%
85.01
+4.37%
81.45
Capital Lease Obligations
43.56
+4.44%
41.71
+12.73%
37.00
+9.98%
33.64
Net Tangible Assets
381.03
+5.63%
360.72
-2.20%
368.84
+8.83%
338.90
Tangible Book Value
381.03
+5.63%
360.72
-2.20%
368.84
+8.83%
338.90
Available For Sale Securities
—
—
—
0.14
Current Provisions
—
—
—
0.05
Foreign Currency Translation Adjustments
—
—
—
-3.10
Interest Payable
4.19
-0.29%
4.21
+41950.00%
0.01
—
Investmentin Financial Assets
—
—
—
0.14
Non Current Accrued Expenses
—
—
0.98
-55.85%
2.21
Other Equity Interest
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-10.71
-141.10%
26.06
+786.43%
2.94
+105.97%
-49.21
Cash Flow From Continuing Operating Activities
-10.71
-141.10%
26.06
+786.43%
2.94
+105.97%
-49.21
Net Income From Continuing Operations
-35.51
+30.48%
-51.09
+7.60%
-55.29
-5.22%
-52.54
Depreciation Amortization Depletion
3.27
-22.31%
4.20
+2.79%
4.09
-23.34%
5.33
Depreciation
3.27
-22.31%
4.20
+2.79%
4.09
-23.34%
5.33
Amortization Cash Flow
—
—
—
—
Depreciation And Amortization
3.27
-22.31%
4.20
+2.79%
4.09
-23.34%
5.33
Amortization Of Intangibles
—
—
—
—
Other Non Cash Items
4.46
+18.96%
3.75
+82.13%
2.06
-0.63%
2.07
Stock Based Compensation
37.70
+10.26%
34.19
+5.30%
32.47
-1.27%
32.89
Provisionand Write Offof Assets
—
—
—
—
Asset Impairment Charge
—
—
—
—
Deferred Tax
14.79
+486.87%
-3.82
+34.57%
-5.84
-65.29%
-3.53
Deferred Income Tax
14.79
+486.87%
-3.82
+34.57%
-5.84
-65.29%
-3.53
Operating Gains Losses
-6.38
-243.42%
4.45
-67.80%
13.83
+208.06%
-12.80
Unrealized Gain Loss On Investment Securities
-19.73
-35.34%
-14.58
0.00
0.00
Net Foreign Currency Exchange Gain Loss
-6.38
-1165.94%
0.60
-95.67%
13.83
+195.48%
-14.48
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-9.30
-119.00%
48.95
+321.09%
11.62
+148.11%
-24.16
Change In Receivables
-7.34
+40.59%
-12.35
+30.90%
-17.87
+31.96%
-26.26
Changes In Account Receivables
-7.34
+40.59%
-12.35
+30.90%
-17.87
+31.96%
-26.26
Change In Prepaid Assets
-6.74
+41.90%
-11.60
-235.77%
8.54
+158.15%
-14.69
Change In Payables And Accrued Expense
13.43
-82.95%
78.77
+88.85%
41.71
-10.62%
46.67
Change In Accrued Expense
15.89
-77.78%
71.50
+82.93%
39.09
-6.39%
41.76
Change In Payable
-2.46
-133.77%
7.27
+177.03%
2.62
-46.57%
4.91
Change In Account Payable
-2.46
-133.77%
7.27
+177.03%
2.62
-46.57%
4.91
Change In Other Working Capital
-0.39
-38600.00%
-0.00
+99.99%
-8.01
+68.58%
-25.50
Change In Other Current Assets
-6.18
-46.20%
-4.22
+53.92%
-9.17
-93.89%
-4.73
Change In Other Current Liabilities
-2.09
-27.00%
-1.65
+53.95%
-3.58
-1105.34%
0.36
Investing Cash Flow
-16.34
+95.40%
-355.13
-6446.16%
-5.42
-146.93%
-2.20
Cash Flow From Continuing Investing Activities
-16.34
+95.40%
-355.13
-6446.16%
-5.42
-146.93%
-2.20
Net PPE Purchase And Sale
-4.34
+15.38%
-5.13
+5.46%
-5.42
-146.93%
-2.20
Purchase Of PPE
-4.34
+16.10%
-5.17
+4.65%
-5.42
-146.26%
-2.20
Sale Of PPE
0.00
-100.00%
0.04
0.00
-100.00%
0.01
Capital Expenditure
-4.34
+16.10%
-5.17
+4.65%
-5.42
-146.26%
-2.20
Net Investment Purchase And Sale
-12.00
+96.57%
-350.00
0.00
0.00
Purchase Of Investment
-30.00
+91.43%
-350.00
0.00
0.00
Sale Of Investment
18.00
0.00
0.00
—
Net Intangibles Purchase And Sale
—
—
—
-0.50
Purchase Of Intangibles
—
—
—
-0.50
Net Other Investing Changes
—
—
—
2.89
Financing Cash Flow
12.37
-96.40%
343.88
+901.23%
34.35
-76.39%
145.44
Cash Flow From Continuing Financing Activities
12.37
-96.40%
343.88
+901.23%
34.35
-76.39%
145.44
Net Issuance Payments Of Debt
0.00
-100.00%
352.50
0.00
0.00
Issuance Of Debt
0.00
-100.00%
402.50
0.00
-100.00%
50.00
Repayment Of Debt
0.00
+100.00%
-50.00
0.00
+100.00%
-50.00
Long Term Debt Issuance
0.00
-100.00%
402.50
0.00
-100.00%
50.00
Long Term Debt Payments
0.00
+100.00%
-50.00
0.00
+100.00%
-50.00
Net Long Term Debt Issuance
0.00
-100.00%
352.50
0.00
0.00
Net Common Stock Issuance
0.00
0.00
0.00
-100.00%
139.51
Cash Dividends Paid
—
—
—
0.00
Proceeds From Stock Option Exercised
12.37
+81.93%
6.80
-80.20%
34.35
+254.23%
9.70
Net Other Financing Charges
—
-15.42
—
-3.77
Changes In Cash
-14.68
-199.11%
14.81
-53.51%
31.86
-66.12%
94.04
Effect Of Exchange Rate Changes
26.66
+1660.83%
-1.71
-120.60%
8.29
+165.58%
-12.65
Beginning Cash Position
455.73
+2.96%
442.63
+9.98%
402.47
+25.35%
321.08
End Cash Position
467.71
+2.63%
455.73
+2.96%
442.63
+9.98%
402.47
Free Cash Flow
-15.05
-172.06%
20.89
+940.56%
-2.48
+95.17%
-51.41
Interest Paid Supplemental Data
10.06
+8.96%
9.23
—
4.48
Income Tax Paid Supplemental Data
4.64
+810.39%
0.51
-47.80%
0.98
+27.71%
0.77
Common Stock Issuance
0.00
0.00
0.00
-100.00%
139.51
Interest Paid CFF
—
—
—
-4.38
Issuance Of Capital Stock
0.00
0.00
0.00
-100.00%
139.51
Taxes Refund Paid
—
—
—
-0.75
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category